Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Humanin

HN, S14G-Humanin

Quick Stats
Studies 491
Trials 100
Score 3
2015 pubmed 37 citations

The Potent Humanin Analogue (HNG) Protects Germ Cells and Leucocytes While Enhancing Chemotherapy-Induced Suppression of Cancer Metastases in Male Mice.

Lue. YanHe Y; Swerdloff. Ronald R; Wan. Junxiang J; Xiao. Jialin J; French. Samuel S; Atienza. Vince V; Canela. Victor V; Bruhn. Kevin W KW; Stone. Brian B; Jia. Yue Y; Cohen. Pinchas P; Wang. Christina C

Key Findings

  • HNG shields immune cells and germ cells from cyclophosphamide‑induced damage in male mice
  • Combining HNG with cyclophosphamide further reduces lung metastases compared to either alone
  • HNG lowers plasma IGF‑1 levels, acting like a caloric‑restriction mimetic

Practical Outcomes

  • The study suggests humanin analogues could one day be used to protect the body during chemotherapy and possibly aid longevity by lowering IGF‑1, but human safety and dosing are still unknown. Biohackers should wait for clinical trials before trying HNG as a supplement.

Summary

In mice, a stronger version of the peptide humanin (called HNG) helped protect white blood cells and sperm‑producing cells from the damage caused by the chemo drug cyclophosphamide, while also making the drug better at stopping cancer spread. It also lowered a growth hormone (IGF‑1) linked to aging. These results are promising but only in animals, so they don’t yet translate into a safe, proven protocol for people.

Abstract

Humanin is a peptide that is cytoprotective against stresses in many cell types. We investigated whether a potent humanin analogue S14G-humanin (HNG) would protect against chemotherapy-induced damage to normal cells without interfering with the chemotherapy-induced suppression of cancer cells. Young adult male mice were inoculated iv with murine melanoma cells. After 1 week, cancer-bearing mice were randomized to receive either: no treatment, daily ip injection of HNG, a single ip injection of cyclophosphamide (CP), or CP+HNG and killed at the end of 3 weeks. HNG rescued the CP-induced suppression of leucocytes and protected germ cell from CP-induced apoptosis. Lung metastases were suppressed by HNG or CP alone, and further suppressed by CP+HNG treatment. Plasma IGF-1 levels were suppressed by HNG with or without CP treatment. To investigate whether HNG maintains its protective effects on spermatogonial stem cells, sperm output, and peripheral leucocytes after repeated doses of CP, normal adult male mice received: no treatment, daily sc injection of HNG, 6 ip injections of CP at 5-day intervals, and the same regimens of CP+HNG and killed at the end of 4 weeks of treatment. Cauda epididymal sperm counts were elevated by HNG and suppressed by CP. HNG rescued the CP-induced suppression of spermatogonial stem cells, sperm count and peripheral leucocytes. We conclude that HNG 1) protects CP-induced loss of male germ cells and leucocytes, 2) enhances CP-induced suppression of cancer metastases, and 3) acts as a caloric-restriction mimetic by suppressing IGF-1 levels. Our findings suggest that humanin analogues may be promising adjuvants to chemotherapy.

Study Information

Provider

pubmed

Year

2015

Date

2015-09-18T00:00:00.000Z

DOI

10.1210/en.2015-1542

Citations

37

References

52